XML 83 R62.htm IDEA: XBRL DOCUMENT v3.22.0.1
INCENTIVE STOCK PLANS (Tables)
12 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs
A summary of our stock-based compensation cost is presented below:
 202120202019
Selling and general expenses$8,255 $6,839 $6,416 
Cost of sales816 693 378 
Timber and Timberlands, net (a)206 170 110 
Other operating expense, net (b)— 324 — 
Total stock-based compensation$9,277 $8,026 $6,904 
Tax benefit recognized related to stock-based compensation expense (c)$487 $421 $362 
(a)Represents amounts capitalized as part of the overhead allocation of timber-related costs.
(b)Represents expense associated with the acceleration of share-based compensation on Pope replacement awards related to qualifying terminations. See Note 27 - Charges for Integration and Restructuring for additional details.
(c)A valuation allowance is recorded against the tax benefit recognized as we do not expect to be able to realize the benefit in the future.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of our restricted stock is presented below:
202120202019
Restricted shares granted (a)22,140 100,452 24,592 
Weighted average price of restricted shares granted$37.36 $23.15 $30.90 
Intrinsic value of restricted stock outstanding (b)$3,062 $4,666 $5,540 
Grant date fair value of restricted stock vested3,121 2,755 5,339 
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on restricted shares vested869 566 1,610 
(a)The year ended December 31, 2020 includes 69,176 replacement awards issued as a result of the merger with Pope Resources.
(b)Intrinsic value of restricted stock outstanding is based on the market price of the Company’s stock at December 31, 2021.
 2021
Number of
Shares
Weighted
Average Grant
Date Fair Value
Non-vested Restricted Shares at January 1,158,820 $28.47 
Granted22,140 37.36 
Vested (a)(104,917)29.74 
Cancelled(181)34.71 
Non-vested Restricted Shares at December 31,75,862 $29.29 
(a)The year ended December 31, 2021 includes 1,430 replacement awards vested as a result of acceleration due to qualifying terminations.
A summary of our restricted stock units is presented below:
 202120202019
Restricted stock units granted129,290 171,409 103,634 
Weighted average price of restricted stock units granted$33.59 $22.58 $31.51 
Intrinsic value of restricted stock units outstanding (a)$15,095 $7,801 $3,351 
Grant date fair value of restricted stock units vested493 218 
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on restricted stock units vested189 47 
(a)Intrinsic value of restricted stock units outstanding is based on the market price of the Company’s stock at December 31, 2021.
 2021
 Number of
Shares
Weighted
Average Grant
Date Fair Value
Non-vested Restricted Stock Units at January 1,265,522 $25.75 
Granted129,290 33.59 
Vested(18,998)25.94 
Cancelled(1,798)29.37 
Non-vested Restricted Stock Units at December 31,374,016 $28.44 
Schedule of Nonvested Performance-based Units Activity
A summary of our performance share units is presented below:
 202120202019
Common shares reserved for performance shares granted during year 191,203 361,870 232,684 
Weighted average fair value of performance share units granted$36.10 $29.59 $35.99 
Intrinsic value of outstanding performance share units (a)$16,360 $11,711 $10,758 
Fair value of performance shares vested1,738 3,522 6,387 
Cash used to purchase common shares from current and former employees to pay withholding tax requirements on performance shares vested559 992 2,639 
(a)Intrinsic value of outstanding performance share units is based on the market price of the Company's stock at December 31, 2021.
 2021
 Number
of Units
Weighted
Average Grant
Date Fair Value
Outstanding Performance Share units at January 1,398,607 $34.17 
Granted109,259 36.10 
Units Distributed(102,505)40.27 
Outstanding Performance Share units at December 31,405,361 $33.16 
Expected volatility was estimated using daily returns on the Company’s common shares for the three-year period ending on the grant date. The risk-free rate was based on the 3-year U.S. Treasury rate on the date of the award. The dividend yield was not used to calculate fair value as awards granted receive dividend equivalents. The following table provides an overview of the assumptions used in calculating the fair value of the awards granted for the three years ended December 31, 2021:
 202120202019
Expected volatility35.6 %32.6 %18.4 %
Risk-free rate0.4 %0.3 %2.3 %
Schedule of Share-based Compensation, Stock Options, Activity
A summary of the status of our stock options as of and for the year ended December 31, 2021 is presented below:
 2021
 Number of
Shares
Weighted
Average Exercise
Price
(per common share)
Weighted
Average
Remaining
Contractual Term
(in years)
Aggregate
Intrinsic
Value
Options outstanding at January 1,340,985 $34.07 
Exercised(186,590)32.31 
Cancelled or expired(30,225)34.25 
Options outstanding at December 31,124,170 36.67 1.27$458 
Options exercisable at December 31,124,170 $36.67 1.27$458 
A summary of additional information pertaining to our stock options is presented below:
 202120202019
Intrinsic value of options exercised (a)$916 $108 $475 
Cash received from exercise of options5,922 1,368 1,260 
(a)Intrinsic value of options exercised is the amount by which the fair value of the stock on the exercise date exceeded the exercise price of the option.